Search
Total Count 18

AVALON PHARMA - Disclosures

Avalon Pharma renews SAR 54.2M credit facilities deal with SAIB

Argaam 25/08/2025

Avalon Pharma to distribute 11% cash dividend for H1 2025

Argaam 13/08/2025

Avalon Pharma signs EUR 3M contract to market weight loss and obesity products

Argaam 05/08/2025

Avalon Pharma to transfer SAR 25.3M reserve to retained earnings

Argaam 01/06/2025

Avalon Pharma renews SAR 50M credit agreement with Alinma Bank

Argaam 18/05/2025

Avalon Pharma to distribute 12.5% cash dividend for H2 2024

Argaam 13/04/2025

Avalon Pharma secures SAR 30M loan from SIDF

Argaam 26/02/2025

Avalon Pharma secures SAR 30M facilities from SAB

Argaam 04/11/2024

Avalon Pharma obtains SAR 55M credit facilities from Alinma Bank

Argaam 01/08/2024

Avalon Pharma board nods to 7.5% cash dividend for H1 2024

Argaam 30/07/2024

Avalon Pharma obtains SAR 70M credit facilities from Emirates NBD

Argaam 09/07/2024

Avalon Pharma debuts today as 2nd listing on TASI in 2024

Argaam Special 27/02/2024

Avalon Pharma to debut on Tadawul on Feb. 27

Argaam 25/02/2024

Avalon Pharma’s retail IPO 54.3x covered, 2 shares allocated per subscriber

Argaam 07/02/2024

Retail subscription to 600,000 Avalon Pharma shares on TASI begins today

Argaam Special 30/01/2024

Aldukheil Financial Group announces the coverage of Avalon Pharma’s offering for Participating Parties by 138.7 times

Argaam 24/01/2024

AFG sets price range for Avalon Pharma IPO on TASI between SAR 78-82/share

Argaam 11/01/2024

Avalon Pharma issues prospectus to list 6M shares on TASI

Argaam 07/01/2024